Dissecting serum polyclonal antibody escape to SARS-CoV-2 variants by deep mutational learning
Preprint
Abstract
The rapid emergence of SARS-CoV-2 variants harboring multiple receptor-binding domain (RBD) mutations continues to challenge the efficacy of vaccines and antibody therapeutics. While deep mutational scanning (DMS) has been instrumental in mapping single-mutation effects on antibody binding and immune escape, it remains limited in its ability to assess combinatorial mutational landscapes. Here, we extend deep mutational learning (DML), a method integrating combinatorial mutagenesis, yeast surface display, deep sequencing, and machine learning, to analyze serum polyclonal antibody escape. Human sera from COVID-19-vaccinated individuals were screened against diverse RBD variant libraries, validating 300 serum-variant interactions across 10 individuals by comparing predicted and observed binding to 30 RBD variants, confirming accurate mapping of binding and escape profiles. Model performance remained consistent across machine learning architectures, suggesting that serum binding and escape are governed by distinct, localized RBD sequence features. Notably, escape profiles were highly individualized, whereas binding signatures were more conserved, reflecting convergent epitope targeting. This approach highlights the potential of DML to generalize beyond observed RBD variants, assess cohort-specific immune breadth, and inform vaccine and therapeutic design in the face of viral evolution.Keywords
All Related Versions
- Published version: Cell Reports Methods, 6 (6), 101417.
This publication has 34 references indexed in Scilit:
- Meta learning addresses noisy and under-labeled data in machine learning-guided antibody engineeringCell Systems, 2024
- Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domainCell, 2022
- Yeast Surface Display2022
- Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsCell Reports, 2021
- SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2Cell, 2021
- The antigenic anatomy of SARS-CoV-2 receptor binding domainCell, 2021
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodiesCell Host & Microbe, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesCell, 2020